Martin Currie Ltd. bought a new position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 5,550 shares of the business services provider's stock, valued at approximately $450,000.
Other hedge funds also recently modified their holdings of the company. Geneva Capital Management LLC lifted its stake in Exponent by 11.2% in the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock valued at $141,517,000 after buying an additional 176,152 shares in the last quarter. BLI Banque de Luxembourg Investments acquired a new stake in shares of Exponent during the fourth quarter worth $12,564,000. Nuveen LLC acquired a new position in Exponent in the 1st quarter worth $10,828,000. Barclays PLC increased its holdings in Exponent by 88.5% during the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after purchasing an additional 85,395 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. raised its stake in shares of Exponent by 17.3% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 506,784 shares of the business services provider's stock valued at $41,250,000 after purchasing an additional 74,605 shares during the period. Institutional investors and hedge funds own 92.37% of the company's stock.
Exponent Trading Up 0.7%
Shares of Exponent stock traded up $0.48 during trading on Tuesday, reaching $69.60. The stock had a trading volume of 983,239 shares, compared to its average volume of 315,753. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 34.80 and a beta of 0.89. The stock has a fifty day moving average price of $73.29 and a two-hundred day moving average price of $78.48. Exponent, Inc. has a 52 week low of $63.81 and a 52 week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. The firm had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.57 EPS. On average, equities analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent's dividend payout ratio (DPR) is currently 60.00%.
Insider Activity
In other Exponent news, VP Joseph Sala sold 1,595 shares of the company's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total value of $112,670.80. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP John Pye sold 2,000 shares of the stock in a transaction that occurred on Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president owned 29,204 shares in the company, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,064 shares of company stock valued at $735,621. 1.60% of the stock is owned by insiders.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.